Calcium deregulation and mitochondrial bioenergetics in GDAP1-related CMT disease

24Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

The pathology of Charcot-Marie-Tooth (CMT), a disease arising from mutations in different genes, has been associated with an impairment of mitochondrial dynamics and axonal biology of mitochondria. Mutations in ganglioside-induced differentiation-associated protein 1 (GDAP1) cause several forms of CMT neuropathy, but the pathogenic mechanisms involved remain unclear. GDAP1 is an outer mitochondrial membrane protein highly expressed in neurons. It has been proposed to play a role in different aspects of mitochondrial physiology, including mitochondrial dynamics, oxidative stress processes, and mitochondrial transport along the axons. Disruption of the mitochondrial network in a neuroblastoma model of GDAP1-related CMT has been shown to decrease Ca 2+ entry through the store-operated calcium entry (SOCE), which caused a failure in stimulation of mitochondrial respiration. In this review, we summarize the different functions proposed for GDAP1 and focus on the consequences for Ca 2+ homeostasis and mitochondrial energy production linked to CMT disease caused by different GDAP1 mutations.

Cite

CITATION STYLE

APA

González-Sánchez, P., Satrústegui, J., Palau, F., & Del Arco, A. (2019, January 2). Calcium deregulation and mitochondrial bioenergetics in GDAP1-related CMT disease. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms20020403

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free